.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, West Coast Cure concentrated 43.31% of sales in Vapor Pens with 5.81% year-over-year growth but a 0.61% month-over-month dip, while Pre-Roll held 19.17% share with a 4.44% YoY decline against a 6.35% MoM rebound. Flower accounted for 21.61% share with an 8.58% YoY contraction and a steeper 15.02% MoM drop, whereas Concentrates at 15.00% share gained 12.80% YoY and 5.50% MoM; Edible remained marginal at 0.92% share with a 41.66% YoY and 16.63% MoM decline. With an overall average price down 54.14% YoY to $20.28 and Vapor Pens pricing at $19.19, the mix indicates unit-led growth and deeper reliance on inhalable formats; the pattern implies the brand’s volume is migrating toward lower-priced, faster-turn segments while Flower and Edible recede.
Positioning-wise, a 13th rank in California Vapor Pens alongside a 5.81% YoY gain but 0.61% MoM slip suggests middle-tier traction that can be defended by leaning into Concentrates’ 12.80% YoY and 5.50% MoM momentum and Pre-Roll’s 6.35% MoM bounce. The simultaneous 15.02% MoM retreat in Flower and 41.66% YoY erosion in Edible reduce diversification risk-buffer, pushing the brand to prioritize inhalables where share already totals 78.47%; this implies West Coast Cure’s competitive footing is best sustained by reinforcing pen and concentrate assortment while treating Flower as a volatility source rather than a growth pillar.
Competitive Landscape
West Coast Cure ranks #13 in CA Vapor Pens in June 2026, improving 2 positions from #15 year over year, but slipping 1 position from #12 in March 2026; the brand’s peak at #7 in June 2024 contrasts with a 6-rank slide since that peak, indicating momentum has not returned to prior levels. Competitively, STIIIZY held #1 with a -7.0% YoY sales change while Jetty Extracts climbed from #5 to #3 with +47.3% YoY sales growth, and Raw Garden remained #2 with +11.0% YoY, framing West Coast Cure’s 2-rank YoY gain as lagging versus faster risers; given the 1-rank decline over the last 3 months alongside competitors moving up 2 ranks or more, the trajectory implies stabilization rather than a return to top-10 unless share-accretive moves outpace peers.
Notable Products
CUREpen - Northern Lights Distillate Cartridge (1g) posted the steepest decline in June 2026 at -11.7% while sliding to rank 7, contrasting with Curebar 2.0 - OG Kush Live Resin Disposable (1g) up 15.6% at rank 4; this divergence indicates consumer trade-up toward live resin formats within the same aisle. CUREpen - Skywalker OG Distillate Cartridge (1g) in rank 1 grew 7.3% as CUREpen - Gas OG Distillate Oil Cartridge (1g) in rank 3 slipped -2.2%, and with seven of the top ten in Vapor Pens, the category concentration implies portfolio dependence on pen SKUs even as subformat preference shifts. The CUREbar - P'SSY Juice Distillate Oil Disposable (1g) held rank 6 with a 3.6% lift against Northern Lights’ double-digit drop, pointing to disposables absorbing demand that distillate carts are losing. The mix suggests West Coast Cure is tilting toward higher-velocity disposables and live resin offerings in Vapor Pens while legacy distillate SKUs require renovation or sharper pricing.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
